Nothing Special   »   [go: up one dir, main page]

Callaghan et al., 2015 - Google Patents

Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18 F] PBR102 and [18 F] PBR111 in a model of excitotoxin-induced …

Callaghan et al., 2015

Document ID
13665758666763507986
Author
Callaghan P
Wimberley C
Rahardjo G
Berghofer P
Pham T
Jackson T
Zahra D
Bourdier T
Wyatt N
Greguric I
Howell N
Siegele R
Pastuovic Z
Mattner F
Loc’h C
Gregoire M
Katsifis A
Publication year
Publication venue
European journal of nuclear medicine and molecular imaging

External Links

Snippet

Purpose The in vivo binding parameters of the novel imidazopyridine TSPO ligand [18 F] PBR102 were assessed and compared with those of [18 F] PBR111 in a rodent model of neuroinflammation. The validity of the key assumptions of the simplified reference tissue …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/507—Clinical applications involving determination of haemodynamic parameters, e.g. perfusion CT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/50—Clinical applications
    • A61B6/508—Clinical applications for non-human patients

Similar Documents

Publication Publication Date Title
Eary et al. 2-[C-11] thymidine imaging of malignant brain tumors
Zimmer et al. PET radiotracers for molecular imaging in the brain: past, present and future
Varrone et al. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18 F] FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients
Dedeurwaerdere et al. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy
Hanaoka et al. FBPA PET in boron neutron capture therapy for cancer: prediction of 10 B concentration in the tumor and normal tissue in a rat xenograft model
Wu et al. A novel PET marker for in vivo quantification of myelination
Li et al. Assessment of test-retest reproducibility of [18 F] SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
McParland et al. The clinical safety, biodistribution and internal radiation dosimetry of [18 F] fluciclovine in healthy adult volunteers
Lavisse et al. [18 F] DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain
Watanabe et al. Biodistribution and radiation dosimetry of the novel hypoxia PET probe [18 F] DiFA and comparison with [18 F] FMISO
Autio et al. Absorption, distribution and excretion of intravenously injected 68 Ge/68 Ga generator eluate in healthy rats, and estimation of human radiation dosimetry
Tsukada et al. Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
Uhl et al. Radionuclides in drug development
Callaghan et al. Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18 F] PBR102 and [18 F] PBR111 in a model of excitotoxin-induced neuroinflammation
Laćan et al. Cyclosporine, a P-glycoprotein modulator, increases [18 F] MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies
Warnock et al. A first-in-man PET study of [18 F] PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5
Shen et al. Further validation to support clinical translation of [18 F] FTC-146 for imaging sigma-1 receptors
Tang et al. Preclinical evaluation of a novel TSPO PET ligand 2-(7-butyl-2-(4-(2-[18 F] fluoroethoxy) phenyl)-5-methylpyrazolo [1, 5-a] pyrimidin-3-yl)-N, N-diethylacetamide (18 F-VUIIS1018A) to image glioma
Dunphy et al. First-in-human trial of epichaperome-targeted PET in patients with cancer
Takahata et al. A human PET study of [11 C] HMS011, a potential radioligand for AMPA receptors
Al-Khishman et al. TSPO PET detects acute neuroinflammation but not diffuse chronically activated MHCII microglia in the rat
Casteels et al. Preclinical evaluation and quantification of [18 F] MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
Borroni et al. Pre-clinical characterization of [11C] R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography
Kubota et al. A first-in-human study of 11 C-MTP38, a novel PET ligand for phosphodiesterase 7
Yuan et al. Targeting phosphatidylethanolamine with fluorine-18 labeled small molecule probe for apoptosis imaging